1-17 of 17
Feng Zhou
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Bromodomain and Extra-Terminal Inhibitor INCB057643 (LIMBER-103) in Patients with Relapsed or Refractory Myelofibrosis and Other Advanced Myeloid Neoplasms: A Phase 1 Study

Justin M. Watts, Alessandro M. Vannucchi, Anthony M. Hunter, Brandon McMahon, Srinivas K. Tantravahi, Alessandra Iurlo, Blanca Xicoy, Francesca Palandri, Emma Searle, Brandi N. Reeves, Prithviraj Bose, Rosa Ayala, Anna B. Halpern, Xuejun Chen, Lea M Burke, Feng Zhou, Fred Zheng, Pankit Vachhani
Journal: Blood
Blood (2023) 142 (Supplement 1): 750.
https://doi.org/10.1182/blood-2023-179428
Published: 2023
Journal Articles

INCB057643 Monotherapy in Patients with Relapsed or Refractory Myelofibrosis: A Phase 1 Study

Justin Watts, Anthony M. Hunter, Alessandra Iurlo, Blanca Xicoy, Francesca Palandri, Brandi Reeves, Alessandro M. Vannucchi, Xuejun Chen, Francis Seguy, Feng Zhou, Fred Zheng, Pankit Vachhani
Journal: Blood
Blood (2022) 140 (Supplement 1): 9696–9697.
https://doi.org/10.1182/blood-2022-169740
Published: 2022
Journal Articles

Efficacy and Safety of Add-on Parsaclisib to Ruxolitinib Therapy in Myelofibrosis Patients With Suboptimal Response to Ruxolitinib: Final Results From a Phase 2 Study

Abdulraheem Yacoub, Uma Borate, Raajit K Rampal, Haris Ali, Eunice Wang, Aaron T. Gerds, Gabriela S. Hobbs, Marina Kremyanskaya, Elliott Winton, Casey O'Connell, Swati Goel, Stephen T Oh, Gary J. Schiller, Albert Assad, Sue Erickson-Viitanen, Feng Zhou, Naval Daver
Journal: Blood
Blood (2022) 140 (Supplement 1): 579–582.
https://doi.org/10.1182/blood-2022-160384
Published: 2022
Journal Articles

Subgroup Analysis from a Phase 2 Study of the Efficacy and Safety of Parsaclisib, a Selective PI3Kδ Inhibitor, in Combination with Ruxolitinib in Patients with Myelofibrosis (MF)

Abdulraheem Yacoub, Uma Borate, Raajit Rampal, Haris Ali, Eunice S. Wang, Aaron T. Gerds, Gabriela Hobbs, Marina Kremyanskaya, Elliott Winton, Casey O'Connell, Swati Goel, Stephen Oh, Gary J. Schiller, Albert Assad, Sue Erickson-Viitanen, Feng Zhou, Naval Daver
Journal: Blood
Blood (2021) 138 (Supplement 1): 3647.
https://doi.org/10.1182/blood-2021-148668
Published: 2021
Journal Articles

A Phase 1/2 Study of INCB000928 As Monotherapy or in Combination with Ruxolitinib in Patients with Anemia Due to Myelofibrosis (INCB 00928-104)

Stephen T. Oh, MD, Jason Gotlib, MD MS, Sanjay Mohan, MD MSCI, Haris Ali, MD, Ekatherine Asatiani, MD, Francis Seguy, Feng Zhou, Srdan Verstovsek, MD PhD
Journal: Blood
Blood (2020) 136 (Supplement 1): 3.
https://doi.org/10.1182/blood-2020-134574
Published: 2020
Journal Articles

A Phase 2 Study of the Safety and Efficacy of INCB050465, a Selective PI3Kδ Inhibitor, in Combination with Ruxolitinib in Patients with Myelofibrosis

Naval G. Daver, MD, Marina Kremyanskaya, MD PhD, Casey O'Connell, MD, Kim-Hien Dao, DO,PhD, Stephen T Oh, MD PhD, Aaron T. Gerds, MDMS, Srdan Verstovsek, MD PhD, Sue Erickson-Viitanen, PhD, Feng Zhou, Albert Assad, MD, Abdulraheem Yacoub, MD
Journal: Blood
Blood (2018) 132 (Supplement 1): 353.
https://doi.org/10.1182/blood-2018-99-111338
Published: 2018
Journal Articles

Preliminary Results from an Ongoing Phase 1/2 Study of INCB053914, a Pan-Proviral Integration Sites for Moloney Virus (PIM) Kinase Inhibitor, in Patients with Advanced Hematologic Malignancies

Michael Byrne, MD, William Donnellan, Manish R Patel, MD, Amer M. Zeidan, MD, Mohamad Cherry, MDMS, Maria R. Baer, MD, Amir T. Fathi, MD MD BS, Jason Kaplan, MD, Feng Zhou, Fred Zheng, MD, April M. Barbour, Michael R. Savona, MD
Journal: Blood
Blood (2017) 130 (Supplement 1): 2585.
https://doi.org/10.1182/blood.V130.Suppl_1.2585.2585
Published: 2017
Journal Articles

HMPL-523, a Novel SYK Inhibitor Showed Anti-Tumor Activities In Vitro and In Vivo

Na Yang, Wei Deng, Qiaoling Sun, Junqing Liang, Linfang Wang, Shiming Fan, Renxiang Tang, Ying Yu, Junen Sun, Feng Zhou, Guangxiu Dai, Weiguo Qing, Weiguo Su, Yongxin Ren
Journal: Blood
Blood (2016) 128 (22): 3970.
https://doi.org/10.1182/blood.V128.22.3970.3970
Published: 2016
Journal Articles

Mitochondria Coordinate Intracellular Metabolism and Epigenetic Gene Regulation during Erythropoiesis

Xin Liu, PhD, Yuannyu Zhang, PhD, Min Ni, PhD, Hui Cao, M.S., Robert Signer, PhD, Dan Li, B.S., Zhimin Gu, PhD, Zeping Hu, PhD, Navdeep Chandel, Ralph DeBerardinis, MD PhD, Feng Zhou, PhD, Zhen Shao, PhD, Jian Xu, PhD
Journal: Blood
Blood (2016) 128 (22): 1038.
https://doi.org/10.1182/blood.V128.22.1038.1038
Published: 2016
Journal Articles

Quantitative Proteomic and Transcriptomic Analysis Reveals Post-Transcriptional Regulation of Mitochondrial Biogenesis during Erythropoiesis

Xin Liu, PhD, Yuannyu Zhang, PhD, Feng Zhou, PhD, Zhen Shao, PhD, Robert Signer, PhD, Hui Cao, M.S., Zeping Hu, PhD, Ralph DeBerardinis, MD PhD, Jian Xu, PhD
Journal: Blood
Blood (2015) 126 (23): 47.
https://doi.org/10.1182/blood.V126.23.47.47
Published: 2015
Journal Articles

Exome Sequencing Identifies Somatic Mutations of DDX3X in Natural Killer/T-Cell Lymphoma

Lu Jiang, PhD, Zhao-Hui Gu, PhD, Zi-Xun Yan, PhD, Xia Zhao, MD, Yin-Yin Xie, PhD, Zi-Guan Zhang, B.S., Chun-Ming Pan, M.S., Yuan Hu, MD, Chang-Ping Cai, MD, Ying Dong, MD, Li Wang, MD, Yang Shen, MD, Guoyu Meng, PhD, Jian-Feng Zhou, MD, PhD, Jian-Da Hu, MD, PhD, Jin-Fen Wang, MD, Lin-Hua Yang, MD, Feng Zhang, MD, Jian-Min Wang, MD, Zhao Wang, MD, Zhi-Gang Peng, MD, Fang-Yuan Chen, MD, Zi-Min Sun, MD, Hao Ding, MD, Jin-Yan Huang, PhD, Yuan-Hua Liu, MD, Jumei Shi, MD, PhD, Jian Hou, MD, Jin-Song Yan, MD, PhD, Jing-Yi Shi, PhD, Lan Xu, PhD, Yang Li, MD, Jing Lu, B.S., Zhong Zheng, MD, Wen Xue, B.S., Wei-Li Zhao, MD, PhD, Zhu Chen, MD, PhD, Sai-Juan Chen, MD, PhD
Journal: Blood
Blood (2014) 124 (21): 1663.
https://doi.org/10.1182/blood.V124.21.1663.1663
Published: 2014
Journal Articles

Highly reinforced structure of a C-terminal dimerization domain in von Willebrand factor

Yan-Feng Zhou, Timothy A. Springer
Journal: Blood
Blood (2014) 123 (12): 1785–1793.
https://doi.org/10.1182/blood-2013-11-523639
Published: 2014
Includes: Supplemental data
Journal Articles

The clinical significance of STAT3 mutation, LDH and β2-MG in T-cell large granular lymphocytic Leukemia

Zhi-Yuan Qiu, M.D., Lei Fan, M.D., Li Wang, M.D., Chun Qiao, Yu-Jie Wu, Jian-Feng Zhou, MD, PhD, Wei Xu, MD, PhD, Jian-Yong Li, MD, PhD
Journal: Blood
Blood (2013) 122 (21): 3483.
https://doi.org/10.1182/blood.V122.21.3483.3483
Published: 2013
Journal Articles

Sequence and structure relationships within von Willebrand factor

Yan-Feng Zhou, Edward T. Eng, Jieqing Zhu, Chafen Lu, Thomas Walz, Timothy A. Springer
Journal: Blood
Blood (2012) 120 (2): 449–458.
https://doi.org/10.1182/blood-2012-01-405134
Published: 2012
Includes: Supplemental data
Journal Articles

CMV Specific T Cells Prevent Progression From Low to High Level Viremia In D+R+ but Not D-R+ Patients.

Mette Hoegh-Petersen, MD, Lina Roa, Yiping Liu, Feng Zhou, Alejandra Ugarte-Torres, Polly Louie, Kevin Fonseca, Faisal Khan, Jan Storek, MD, PhD
Journal: Blood
Blood (2010) 116 (21): 4532.
https://doi.org/10.1182/blood.V116.21.4532.4532
Published: 2010
Journal Articles

Peripheral Neuropathy Profile of Vincristine Sulfate Liposomes Injection (VSLI, Marqibo ® ), a Nanoparticle Vincristine Formulation, in Adult Subjects with Relapsed/Refractory Acute Lymphoblastic Leukemia (ALL) and Non-Hodgkin’s Lymphoma (NHL)

Biao Lu, PhD, Anne E Hagey, MD, Feng Zhou, MS, Steven R. Deitcher, MD
Journal: Blood
Blood (2008) 112 (11): 2928.
https://doi.org/10.1182/blood.V112.11.2928.2928
Published: 2008
Journal Articles

Angiogenesis alteration by defibrotide: implications for its mechanism of action in severe hepatic veno-occlusive disease

Luba Benimetskaya, Sijian Wu, Anatoliy M. Voskresenskiy, Cinara Echart, Jin-Feng Zhou, Joongho Shin, Massimo Iacobelli, Paul Richardson, Kanyalakshmi Ayyanar, C. A. Stein
Journal: Blood
Blood (2008) 112 (10): 4343–4352.
https://doi.org/10.1182/blood-2008-04-149682
Published: 2008